Cargando…

GCT-02. THE LONG-TERM OUTCOMES AND SEQUELAE ANALYSIS OF INTRACRANIAL GERMINOMA FROM 187 PATIENTS IN THE SINGLE INSTITUTE: NECESSITY FOR THE ADAPTATION OF RADIOTHERAPY DOSE AND VOLUME

PURPOSE: We aimed to refine the radiotherapy (RT) volume and dose determinant for disease failures and long-term sequelae in the intracranial germinoma. METHODS: The main treatment for intracranial germinoma was craniospinal RT only (n=51) during 1981–1992 and RT with upfront chemotherapy (CRT) (n=1...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Joo Ho, Kim, Il Han, Eom, Keun-Yong, Kim, Seung Ki, Wang, Kyu-Chang, Kim, Tae Min, Heo, Dae Seog, Kang, Hyoung Jin, Shin, Hee Young
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Germ Cell Tumors
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715557/ http://dx.doi.org/10.1093/neuonc/noaa222.226

Ejemplares similares

GCT-38. RELAPSE PATTERNS OF INTRACRANIAL GERMINOMAS BEFORE AND AFTER ENDOSCOPIC ERA
por: Tsurubuchi, Takao, et al.
Publicado: (2020)

GCT-50. LONG-TERM OUTCOMES OF INTRACRANIAL GERMINOMA IN A SINGLE INSTITUTION
por: Yamamoto, Etsuko, et al.
Publicado: (2020)

GCT-55. INTRACRANIAL GERMINOMA ORIGINATING FROM ATYPICAL LOCATION WITH SUBCLINICAL ADH INSUFFICIENCY
por: Kuranari, Yuki, et al.
Publicado: (2020)

GCT-35. SALVAGE CRANIOSPINAL IRRADIATION FOR RECURRENT GERMINOMAS
por: Kanamori, Masayuki, et al.
Publicado: (2020)

GCT-69. VOLUMETRIC CHANGE BEFORE CHEMORADIOTHERAPY AND INFLUENCE OF DIAGNOSTIC RADIATION EXPOSURE IN INTRACRANIAL GERMINOMAS
por: Kagawa, Naoki, et al.
Publicado: (2020)

GCT-56. ACUTE MYELOID LEUKEMIA FOLLOWING CHEMORADIOTHERAPY FOR INTRACRANIAL GERMINOMA: A CASE REPORT
por: Nakaya, Masato, et al.
Publicado: (2020)

GCT-51. IMMUNE CHECKPOINT MOLECULES AND TUMOR INFILTRATING LEUKOCYTES IN THE TUMOR MICROENVIRONMENT ARE ASSOCIATED WITH THE GROWTH OF INTRACRANIAL GERMINOMAS
por: Nishimoto, Masaaki, et al.
Publicado: (2020)

GCT-21. CENTRAL NERVOUS SYSTEM GERMINOMA - PONDERING THE NEXT STEPS
por: AbdelBaki, Mohamed S, et al.
Publicado: (2020)

GCT-20. EVALUATION OF NEURORADIOLOGICAL RESPONSE TO INDUCTION CHEMOTHERAPY FOR PATIENTS WITH LOCALISED GERMINOMA IN THE SIOP CNS GCT II TRIAL
por: Bison, Brigitte, et al.
Publicado: (2020)

GCT-49. EVALUATION OF THE PERIOPERATIVE AND POSTOPERATIVE COURSE OF SURGERY OF PINEAL GERMINOMA ACCORDING TO THE SIOP CNS GCT 96 TRIAL
por: Shabo, Ehab, et al.
Publicado: (2020)

GCT-44. A CASE OF INTRACRANIAL GERMINOMA WHICH RECURRED IN THE SPINAL CORD 13 YEARS AFTER THE INITIAL TREATMENT
por: Murota, Yasuhiro, et al.
Publicado: (2020)

GCT-23. MULTI-INSTITUTIONAL ANALYSIS OF TREATMENT MODALITIES IN BASAL GANGLIA AND THALAMIC GERMINOMA
por: Graham, Richard T, et al.
Publicado: (2020)

GCT-11. 24 Gy whole ventricular radiotherapy alone is sufficient for disease control in localised germinoma in CR after initial chemotherapy – final of the SIOP CNS GCT II study
por: Calaminus, Gabriele, et al.
Publicado: (2022)

GCT-76. 24Gy WHOLE VENTRICULAR RADIOTHERAPY ALONE IS SUFFICIENT FOR DISEASE CONTROL IN LOCALISED GERMINOMA IN CR AFTER INITIAL CHEMOTHERAPY – EARLY RESULTS OF THE SIOP CNS GCT II STUDY
por: Calaminus, Gabriele, et al.
Publicado: (2020)

GCT-67. CENTRAL NERVOUS SYSTEM GERMINOMA IN TWO CAUCASIAN AMERICAN SIBLINGS WITH AUTISM SPECTRUM DISORDER
por: Toll, Stephanie, et al.
Publicado: (2020)

GCT-61. CORRELATION OF PATTERNS OF DISEASE RECURRENCE WITH RADIOTHERAPY TECHNIQUES AND DOSE IN INTRACRANIAL GERM CELL TUMOURS (icGCT): LESSONS FROM THE UK COHORT OF SIOP GCT96 STUDY
por: Ajithkumar, Thankamma, et al.
Publicado: (2020)

GCT-24. RELAPSE PATTERN AND QUALITY OF LIFE IN PATIENTS WITH LOCALIZED GERMINOMA ORIGINATING FROM BASAL GANGLIA REGION
por: Li, Bo
Publicado: (2020)

GCT-14. The Impact of Residual Disease on the Outcomes of Central Nervous System Germinomas – A Single Institution Experience
por: Cantor, Evan, et al.
Publicado: (2022)

GCT-08. Patients with Metastatic Central Nervous System Germinoma Involving the Basal Ganglia and Thalami, a Case Series
por: Abu-Arja, Mohammad, et al.
Publicado: (2022)

GCT-12. INTRACRANIAL GROWING TERATOMA SYNDROME: CLINICAL IMPLICATION FROM SINGLE UNIVERSITY EXPERIENCES
por: Kim, Chae-Yong, et al.
Publicado: (2020)

GCT-22. OUTCOMES OF CHILDREN WITH LOCALIZED AND METASTATIC GERMINOMA TREATED WITH CHEMOTHERAPY FOLLOWED BY RADIATION THERAPY WITHOUT PRIMARY TUMOR BOOST
por: Bajin, Inci Yaman, et al.
Publicado: (2022)

GCT-70. INTRACRANIAL GROWING TERATOMA SYNDROME IN CHILDREN
por: Febres, Maria Carter, et al.
Publicado: (2020)

GCT-08. PROTON BEAM RADIOTHERAPY FOR PEDIATRIC AND YOUNG-ADULT PATIENTS WITH INTRACRANIAL GERM CELL TUMOR
por: Sugiyama, Minako, et al.
Publicado: (2020)

GCT-13. THE TREATMENT OUTCOMES OF INTRACRANIAL GERM CELL TUMORS WITH KSPNO PROTOCOL: SINGLE CENTER RETROSPECTIVE ANALYSIS
por: Go, Kyeong-O, et al.
Publicado: (2020)

GCT-14. SECOND-LOOK SURGERY FOR INTRACRANIAL GERM CELL TUMORS
por: Ogiwara, Hideki
Publicado: (2020)

GCT-13. KRAS MUTATION IN PEDIATRIC INTRACRANIAL GERM CELL TUMORS
por: Khaiman, Chusana, et al.
Publicado: (2022)

GCT-17. WHAT IS THE CLINICAL OUTCOME OF PROTON BEAM THERAPY FOR PATIENTS WITH INTRACRANIAL GERM CELL TUMOR IN KOREA?
por: Youn, Sang Hee, et al.
Publicado: (2020)

GCT-53. CASE OF INTRACRANIAL GROWING TERATOMA SYNDROME WITH DIFFICULTY IN TIMING OF RESECTION
por: Yoshitake, Hidenobu, et al.
Publicado: (2020)

GCT-31. DIAGNOSTIC CAPABILITY OF CSF-PLAP ON INTRACRANIAL GERM CELL TUMOR
por: Okamoto, Michinari, et al.
Publicado: (2020)

GCT-34. ELUCIDATION OF THE MECHANISMS OF TUMORIGENESIS IN INTRACRANIAL GERM CELL TUMOR BY WHOLE GENOME SEQUENCE
por: Yamagishi, Yuki, et al.
Publicado: (2020)

GCT-41. RESPONSE-BASED RADIATION THERAPY IN PATIENTS WITH NEWLY DIAGNOSED CENTRAL NERVOUS SYSTEM LOCALIZED GERMINOMA: A CHILDREN’S ONCOLOGY GROUP (COG) PROSPECTIVE PHASE 2 CLINICAL TRIAL
por: Bartels, Ute, et al.
Publicado: (2020)

GCT-48. OUTCOME OF CNS MALIGNANT NON-GERMINOMATOUS GERM CELL TUMORS (GCT) WITH AFP > 1000 ng/ml AT DIAGNOSIS TREATED ACCORDING TO SIOP CNS GCT 96
por: Calaminus, Gabriele, et al.
Publicado: (2020)

GCT-65. INCIDENCE AND OUTCOME OF INTRACRANIAL MALIGNANT GERM CELL TUMOURS DIAGNOSED IN WESTERN DENMARK IN THE LAST DECADE
por: Lassen-Ramshad, Yasmin, et al.
Publicado: (2020)

GCT-57. ARE MELATONIN LEVELS A RELIABLE MARKER FOR INTRACRANIAL GERM CELL TUMORS POST TREATMENT DEFICIENCY?
por: Cappellano, Andréa M, et al.
Publicado: (2020)

GCT-46. MULTI-KINASE INHIBITORS AS NOVEL THERAPEUTIC AGENTS AGAINST INTRACRANIAL NON-GERMINOMATOUS GERM CELL TUMORS
por: Uchida, Eita, et al.
Publicado: (2020)

GCT-29. DOES TUMOUR MARKER DECLINE PREDICT OUTCOME IN INTRACRANIAL NON-GERMINOMATOUS GERM CELL TUMOURS (NGGCTs)?
por: Conter, Cecile Faure, et al.
Publicado: (2020)

GCT-37. PREVALENCE OF AUTISM SPECTRUM DISORDER AND OTHER NEURODEVELOPMENTAL DISORDERS IN PEDIATRIC PATIENTS WITH INTRACRANIAL GERM CELL TUMORS
por: Liu, Kevin X, et al.
Publicado: (2020)

GCT-75. ISOLATED PITUITARY STALK THICKENING
por: Bennett, Julie, et al.
Publicado: (2020)

GCT-28. RECURRENCE PATTERN AND SURVIVAL FOR RELAPSED INTRACRANIAL NON-GERMINOMATOUS GERM CELL TUMORS: A SINGLE-INSTITUTION EXPERIENCE
por: Wen, Lei, et al.
Publicado: (2020)

GCT-72. ANALYSIS OF microRNA EXPRESSION PROFILE OF INTRACRANIAL GERM CELL TUMORS: A PROMISING TOOL FOR DIFFERENTIAL DIAGNOSIS
por: Nakano, Yoshiko, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_k6ll4gokp6l8fsfepvaqgqek7r